Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jun;99(6):1092-9.
doi: 10.1111/j.1349-7006.2008.00815.x.

Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells

Ying Cao  1 , Tracy M Bryan, Roger R Reddel
Affiliations
Review

Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells

Ying Cao et al. Cancer Sci. 2008 Jun.

Abstract

Telomerase is a ribonucleoprotein enzyme complex that adds telomeric repeats to the ends of chromosomes. The core telomerase components are the telomerase reverse transcriptase (TERT) catalytic subunit, and the telomerase RNA (TR) template subunit. In most cancers, telomerase is expressed at levels that are substantially higher than in normal cells. A known consequence of telomerase up-regulation which is considered to play a critical role in oncogenesis is maintenance of telomere length, and thus evasion by cancer cells of the normal limits on proliferation that are associated with the steady decrease in telomere length that accompanies proliferation of normal cells. It has also been suggested that telomerase up-regulation confers other advantages on cancer cells independent of its enzymatic activity. The mechanisms responsible for up-regulation of telomerase in cancer are incompletely understood. Here we review evidence suggesting that this frequently results from increased copy number of the genes encoding telomerase components. The TERT gene is located at human chromosome band 5p15.33, and the telomerase RNA component (TERC) gene that encodes TR is at 3q26.3. Chromosomal gains and gene amplifications involving chromosome arms 5p and 3q are among the most frequent in human tumors. Increased TERT and TERC gene dosage has been detected frequently in a variety of human cancers, and clonal evolution of cells with increased TERT or TERC copy number has been observed, suggesting a growth advantage in cells with increased TERT or TERC gene dosage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Human telomerase reverse transcriptase (hTERT) amplification in B80‐TERT1 cells detected by fluorescence in situ hybridization analysis using the full length hTERT cDNA as a probe. Fluorescein‐avidin detection of hTERT is shown in green. DAPI staining of the nucleus is shown in blue. Top and bottom panels are two representative images from the whole cell population.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405–13. - PubMed
    1. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science 2007; 315: 1850–3. - PubMed
    1. Nakamura TM, Morin GB, Chapman KB et al . Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–9. - PubMed
    1. Feng J, Funk WD, Wang SS et al . The RNA component of human telomerase. Science 1995; 269: 1236–41. - PubMed
    1. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999; 402: 551–5. - PubMed

Publication types